Two Sigma Advisers’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Two Sigma Advisers’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,441	Closed	-$26K	–	2798
2022 Q3	$26K	Buy	1,441 +1,085	+305%	+$38K	﹤0.01%	2430
2022 Q2	$18K	Buy	+356	New	+$26.5K	﹤0.01%	2560
2019 Q3	–	Sell	-304	Closed	-$35K	–	2453
2019 Q2	$35K	Sell	304 -14	-4%	-$2.22K	﹤0.01%	2271
2019 Q1	$54K	Buy	318 +1	+0.3%	+$171	﹤0.01%	2229
2018 Q4	$38K	Buy	317 +32	+11%	+$4.91K	﹤0.01%	2292
2018 Q3	$43K	Buy	285 +2	+0.7%	+$836	﹤0.01%	2183
2018 Q2	$187K	Buy	283 +140	+98%	+$105K	﹤0.01%	2210
2018 Q1	$146K	Buy	+143	New	+$120K	﹤0.01%	2189
2015 Q3	–	Sell	-35	Closed	-$25K	–	2038
2015 Q2	$25K	Buy	+35	New	+$37.3K	﹤0.01%	1850

Other funds holding AMPE

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ARG

Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Two Sigma Advisers's AMPE Position: Q4 2022 in Review

Two Sigma Advisers sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 1,441 shares — an estimated $26K sold.

Two Sigma Advisers first reported a position in AMPE in Q2 2015 and held it in 9 quarters. The position peaked at $187K in Q2 2018. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

Two Sigma Advisers reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
Two Sigma Advisers sold 1,441 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $26K.
Two Sigma Advisers first reported a position in Ampio Pharmaceuticals Inc. in Q2 2015 and held it in 9 quarters.
Two Sigma Advisers's Ampio Pharmaceuticals Inc. position peaked at $187K in Q2 2018.
32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.